| Name: | Cinnarizine EP Impurity C |
| Catalogue No. | VL195004 |
| CAS No. | 95062-18-3 |
| Molecular Formula | C35H35F2N2.Cl |
| Molecular Weight | 557.11 |
| Status | In-stock |
| IUPAC Name | (4-(Diphenylmethyl)-1,1-bis[(E)-3-phenylprop-2-enyl]piperazinium chloride; |
| Description | Cinnarizine EP Impurity C (CAS No: 95062-18-3) or (4-(Diphenylmethyl)-1,1-bis[(E)-3-phenylprop-2-enyl]piperazinium chloride is an adulteration of Cinnarizine. Cinnarizine is a selective calcium blocker that has been used to treat and prevent vertigo. Cinnarizine is a potentially risky drug known to induce extrapyramidal reactions and depression. |
| References | Haress, Nadia G. “Cinnarizine.” Profiles of Drug Substances, Excipients and Related Methodology, 2015, pp. 1–41, https://doi.org/10.1016/bs.podrm.2015.01.001. Micheli, F., et al. “Flunarizine- and Cinnarizine-Induced Extrapyramidal Reactions.” Neurology, vol. 37, no. 5, May 1987, pp. 881–81, https://doi.org/10.1212/wnl.37.5.881. |
